The first new Alzheimer’s treatment in more than 20 years was hailed as a breakthrough when regulators approved it more
Continue reading »
mypharmacynews.com
Home »
The first new Alzheimer’s treatment in more than 20 years was hailed as a breakthrough when regulators approved it more
Continue reading »The approval of a controversial new drug for Alzheimer’s disease, Aduhelm, is shining a spotlight on mild cognitive impairment —
Continue reading »In June 2021, the Food & Drug Administration (FDA) granted accelerated approval for aducanumab to treat patients with mild cognitive
Continue reading »Research conducted at the University of Kentucky College of Medicine suggests that higher intake of specific nutrients is associated with
Continue reading »Being persistently lonely during midlife (ages 45-64) appears to make people more likely to develop dementia and Alzheimer’s Disease (AD)
Continue reading »West Virginia University scientists used MRI scans to show what happens when ultrasound waves target a specific area of Alzheimer’s
Continue reading »Drug maker Eli Lilly on Monday announced promising results from a small study of an experimental Alzheimer’s disease drug called
Continue reading »The coronavirus has so far killed about 325,000 people in this country, but that staggering toll does not include the
Continue reading »University of Maryland (UMD) and U.S. Food and Drug Administration (FDA) researchers are working together to develop a new X-ray
Continue reading »We will use your email address only for sending you newsletters. Please see our Privacy Notice for details of your
Continue reading »